Amphora™ completed a phase III contraceptive clinical trial.

Read More


Amphora™ offers potential applications for women all over the world.

Read More


Evofem is committed
to giving women access to better healthcare options.

Read More

Empower Women logo_vChange the World

Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.

Latest News


Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora™ as a Contraceptive  

September 22, 2015

San Diego, CA — Evofem, Inc. today announced that a New Drug Application for Amphora has been accepted for filing by the United States Food and Drug Administration (FDA).  The NDA requests FDA approval for Amphora as a non-hormonal, vaginal gel contraceptive. “We are delighted that the FDA has accepted this filing for Amphora,” said…

More News